Lydia Kariuki

Education

Master of Arts in English, Western Connecticut State University.

Lydia Kariuki is a qualified medical nurse and journalist with a diploma in clinical research and medical writing. Her mission is to make peer-reviewed scientific clinical literature accessible to the public. Lydia has had the privilege of interviewing leading experts in the field of cannabis. With a Master of Arts in English from Western Connecticut State University, Lydia brings a strong command of language and communication skills to her work. Her expertise lies in translating complex scientific information into understandable content for a wider audience. Lydia is dedicated to bridging the gap between scientific cannabis research and public understanding. Through her academic background, Lydia strives to provide accurate and engaging information about cannabis to promote awareness and education. Her commitment to delivering clear and insightful content showcases her passion for disseminating knowledge to benefit the public.

Releaf articles

12. 07. 2023

Exploring the benefits of cannabis for cluster headaches

The incidence of cluster headaches in the UK, and in the world generally, is quite low. Roughly 27,000 people in the UK suffer from cluster headaches, with a majority experiencing episodic cluster headaches. Looking past the incidence, cluster headaches can be intimidating and traumatic for anyone. This article highlights studies investigating medicinal cannabis administration in the treatment of cluster headaches and discusses how patients may apply medicinal cannabis to manage the condition.

06. 07. 2023

The CBD market growth - UK Trends and projections

According to MarketWatch, searches for “CBD” and “cannabidiol” hit an estimated 6.4 million in April this year. Of all the health-related searches on Google, CBD ranked number four. This demonstrates the marked interest and enthusiasm surrounding CBD, not only here in the UK, but globally.

06. 07. 2023

What does THC do to the brain?

Delta-9-tetrahydrocannabinol (THC) is a psychoactive molecule present in cannabis that affects key functions of the brain such as the state of consciousness, mood, memory, attention, learning, reaction time, and possibly even the formation of new brain cells. Traditionally, THC has been associated with the intoxicating, euphoria-inducing effects of cannabis, leading many to believe that it lacks therapeutic potential.